|
| Clinical Condition | Altered DC phenotypes | References |
|
| Asthma | pDC (HLA-DR+, CD123+) increased in BALF mDC (HLA-DR+, CD11c+) increased in BALF | [99] |
| Allergic asthma | mDC (BDCA-3+, mannose receptor+) increased in BALF | [100] |
| Allergic asthma | pDC (BDCA4+) with increased FcεRI in blood mDC (CD1c+) with increased FcεRI in blood | [101, 102] |
| Asthma | Increased DC proportions in peripheral blood | [103] |
| Allergic asthma patients challenged with allergen | Increased pDC and mDC in sputum | [104] |
| Asthma | Increase in pDC1 and pDC2 expressing FcεRI | [105] |
| Repeated exposure to allergen | Depletion of mDCs | [23] |
| Asthmatic children | DC2 (CD11c−, CD123high+) decreased in blood | [106] |
| Asthmatic patients | Increased CD1a+ cells in bronchial mucosa | [107] |
| Experimentally elicited allergic rhinitis | pDC increased in nasal mucosa | [108] |
| Asthma | pDC increased; decreased mDC : pDC ratio in blood | [109] |
| Children with asthma | Deficiency of circulating pDC | [110] |
| Atopic patients with chronic rhinosinusitis | Increased FcεRI on DC (CD1+) | [111] |
|